Hence, future studies could be directed towards using these inhibitory compounds in a syngeneic model of metastatic breast cancer to investigate the role of FOXM1 in mobilizing immune cells to facilitate metastatic progression. The gene discussed is FOXM1; the disease is breast cancer.